95 related articles for article (PubMed ID: 18608742)
1. The strand transfer oligonucleotide inhibitors of HIV-integrase.
Snásel J; Rosenberg I; Paces O; Pichová I
J Enzyme Inhib Med Chem; 2009 Feb; 24(1):241-6. PubMed ID: 18608742
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of HIV-1 integrase by modified oligonucleotides derived from U5' LTR.
Snásel J; Rejman D; Liboska R; Tocík Z; Ruml T; Rosenberg I; Pichová I
Eur J Biochem; 2001 Feb; 268(4):980-6. PubMed ID: 11179964
[TBL] [Abstract][Full Text] [Related]
3. Changes to the HIV long terminal repeat and to HIV integrase differentially impact HIV integrase assembly, activity, and the binding of strand transfer inhibitors.
Dicker IB; Samanta HK; Li Z; Hong Y; Tian Y; Banville J; Remillard RR; Walker MA; Langley DR; Krystal M
J Biol Chem; 2007 Oct; 282(43):31186-96. PubMed ID: 17715137
[TBL] [Abstract][Full Text] [Related]
4. 6-oxocytidine containing oligonucleotides inhibit the HIV-1 integrase in vitro.
Brodin P; Pinskaya M; Parsch U; Bischerour J; Leh H; Romanova E; Engels JW; Gottikh M; Mouscadet JF
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):481-6. PubMed ID: 11563063
[TBL] [Abstract][Full Text] [Related]
5. The terminal (catalytic) adenosine of the HIV LTR controls the kinetics of binding and dissociation of HIV integrase strand transfer inhibitors.
Langley DR; Samanta HK; Lin Z; Walker MA; Krystal MR; Dicker IB
Biochemistry; 2008 Dec; 47(51):13481-8. PubMed ID: 18991395
[TBL] [Abstract][Full Text] [Related]
6. The use of a new in vitro reaction substrate reproducing both U3 and U5 regions of the HIV-1 3'-ends increases the correlation between the in vitro and in vivo effects of the HIV-1 integrase inhibitors.
Tramontano E; Onidi L; Esposito F; Badas R; La Colla P
Biochem Pharmacol; 2004 May; 67(9):1751-61. PubMed ID: 15081874
[TBL] [Abstract][Full Text] [Related]
7. [Interactions of HIV-1 DNA heterocyclic bases with viral DNA].
Agapkina IuIu; Tashlitskiĭ VN; Deprez E; Brochon JC; Shugaliĭ AV; Mouscadet JF; Gottikh MB
Mol Biol (Mosk); 2004; 38(5):848-57. PubMed ID: 15554187
[TBL] [Abstract][Full Text] [Related]
8. Azido-containing diketo acid derivatives inhibit human immunodeficiency virus type 1 integrase in vivo and influence the frequency of deletions at two-long-terminal-repeat-circle junctions.
Svarovskaia ES; Barr R; Zhang X; Pais GC; Marchand C; Pommier Y; Burke TR; Pathak VK
J Virol; 2004 Apr; 78(7):3210-22. PubMed ID: 15016842
[TBL] [Abstract][Full Text] [Related]
9. Mode of interaction of G-quartets with the integrase of human immunodeficiency virus type 1.
Cherepanov P; Esté JA; Rando RF; Ojwang JO; Reekmans G; Steinfeld R; David G; De Clercq E; Debyser Z
Mol Pharmacol; 1997 Nov; 52(5):771-80. PubMed ID: 9351967
[TBL] [Abstract][Full Text] [Related]
10. High affinity interaction of HIV-1 integrase with specific and non-specific single-stranded short oligonucleotides.
Caumont A; Jamieson G; de Soultrait VR; Parissi V; Fournier M; Zakharova OD; Bayandin R; Litvak S; Tarrago-Litvak L; Nevinsky GA
FEBS Lett; 1999 Jul; 455(1-2):154-8. PubMed ID: 10428491
[TBL] [Abstract][Full Text] [Related]
11. Development and application of a high-throughput screening assay for HIV-1 integrase enzyme activities.
John S; Fletcher TM; Jonsson CB
J Biomol Screen; 2005 Sep; 10(6):606-14. PubMed ID: 16103418
[TBL] [Abstract][Full Text] [Related]
12. Selectivity for strand-transfer over 3'-processing and susceptibility to clinical resistance of HIV-1 integrase inhibitors are driven by key enzyme-DNA interactions in the active site.
Métifiot M; Johnson BC; Kiselev E; Marler L; Zhao XZ; Burke TR; Marchand C; Hughes SH; Pommier Y
Nucleic Acids Res; 2016 Aug; 44(14):6896-906. PubMed ID: 27369381
[TBL] [Abstract][Full Text] [Related]
13. Disruption of HIV-1 integrase-DNA complexes by short 6-oxocytosine-containing oligonucleotides.
Brodin P; Pinskaya M; Buckle M; Parsch U; Romanova E; Engels J; Gottikh M; Mouscadet JF
Biochemistry; 2002 Feb; 41(5):1529-38. PubMed ID: 11814346
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the strand transfer step of HIV-1 integrase by non-natural dinucleotides.
Chi G; Neamati N; Nair V
Bioorg Med Chem Lett; 2004 Oct; 14(19):4815-7. PubMed ID: 15341930
[TBL] [Abstract][Full Text] [Related]
15. Activity of recombinant HIV-1 integrase on mini-HIV DNA.
Cherepanov P; Surratt D; Toelen J; Pluymers W; Griffith J; De Clercq E; Debyser Z
Nucleic Acids Res; 1999 May; 27(10):2202-10. PubMed ID: 10219094
[TBL] [Abstract][Full Text] [Related]
16. Probing of HIV-1 integrase/DNA interactions using novel analogs of viral DNA.
Agapkina J; Smolov M; Barbe S; Zubin E; Zatsepin T; Deprez E; Le Bret M; Mouscadet JF; Gottikh M
J Biol Chem; 2006 Apr; 281(17):11530-40. PubMed ID: 16500899
[TBL] [Abstract][Full Text] [Related]
17. Alternate strand DNA triple helix-mediated inhibition of HIV-1 U5 long terminal repeat integration in vitro.
Bouziane M; Cherny DI; Mouscadet JF; Auclair C
J Biol Chem; 1996 Apr; 271(17):10359-64. PubMed ID: 8626607
[TBL] [Abstract][Full Text] [Related]
18. A rapid and quantitative assay for inhibition of 3' cleavage activity of HIV-1 integrase.
Rank KB; Fan N; Sharma SK
Antiviral Res; 1997 Sep; 36(1):27-33. PubMed ID: 9330758
[TBL] [Abstract][Full Text] [Related]
19. Structural determinants for HIV-1 integrase inhibition by beta-diketo acids.
Marchand C; Zhang X; Pais GC; Cowansage K; Neamati N; Burke TR; Pommier Y
J Biol Chem; 2002 Apr; 277(15):12596-603. PubMed ID: 11805103
[TBL] [Abstract][Full Text] [Related]
20. Modulation of HIV-1 integrase activity by single-stranded oligonucleotides and their conjugates with eosin.
Korolev S; Knyazhanskaya E; Anisenko A; Tashlitskii V; Zatsepin TS; Gottikh M; Agapkina J
Nucleosides Nucleotides Nucleic Acids; 2011; 30(7-8):651-66. PubMed ID: 21888554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
